Immunize Against Shingles With the New Vaccine, Shingrix

December 2017

Please see the January 2018 CDC recommendations for the use of herpes zoster vaccines.

The new zoster vaccine, Shingrix (SHING-riks), will be preferred over Zostavax...because Shingrix seems more effective.

Patients will hear that Shingrix is about 97% effective at preventing shingles...compared to about 51% with Zostavax.

This works out to preventing one case of shingles over 3 years for every 37 patients getting Shingrix...versus 59 patients with Zostavax.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote